Vertebral Fracture Risk After Once-Weekly Teriparatide Injections: Follow-Up Study of Teriparatide Once-Weekly Efficacy Research (TOWER) Trial

Current Medical Research and Opinion - United Kingdom
doi 10.1185/03007995.2012.761956
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa Healthcare

Related search

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture With Once-Weekly Teriparatide

Case Reports in Orthopedics
2015English

Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2019English

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2016English

New Simulation Model for Bone Formation Markers in Osteoporosis Patients Treated With Once-Weekly Teriparatide

Bone Research
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2014English

Comparison of the Effects of Once-Weekly and Once-Daily rhPTH (1-34) Injections on Promoting Fracture Healing in Rodents

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2017English

Profile of Changes in Bone Turnover Markers During Once-Weekly Teriparatide Administration for 24 Weeks in Postmenopausal Women With Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2013English

Once-Weekly Teriparatide Increases Bone Mineral Density in the Distal 1/10 Radius, but Not in the Distal 1/3 Radius

SpringerPlus
Multidisciplinary
2014English

FRAX and the Effect of Teriparatide on Vertebral and Non-Vertebral Fracture

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes

Pharmacy Today
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy